Moderna Launches Early Trial of Ebola mRNA Vaccine
Source Summary
Moderna has launched an early-stage trial of an Ebola mRNA vaccine. The announcement was made alongside biotech industry news including earnings reports from Novo and Lilly, and staff reductions at Aurora Therapeutics.
